Toxicity study of SARS-CoV-2 Spike protein expressed on Bacillus subtilis spores
Abstract Background The SARS-CoV-2 spike protein is the primary antigen used in most COVID-19 vaccines. To improve protection, especially at mucosal surfaces, a robust and safe delivery system capable of inducing both systemic and mucosal immunity is needed. Bacillus subtilis spores offer a promisin...
Tallennettuna:
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMC
2025-10-01
|
| Sarja: | BMC Microbiology |
| Aiheet: | |
| Linkit: | https://doi.org/10.1186/s12866-025-04186-y |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|